Atea Pharmaceuticals, Inc. (AVIR)
5.145
-0.01
(-0.19%)
USD |
NASDAQ |
Oct 09, 16:00
5.145
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value : 2.021 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.025 |
| October 07, 2026 | 1.968 |
| October 06, 2026 | 1.992 |
| October 05, 2026 | 2.015 |
| October 02, 2026 | 2.015 |
| October 01, 2026 | 2.004 |
| September 30, 2026 | 2.047 |
| September 29, 2026 | 2.035 |
| September 28, 2026 | 2.043 |
| September 25, 2026 | 2.031 |
| September 24, 2026 | 2.031 |
| September 23, 2026 | 2.074 |
| September 22, 2026 | 2.216 |
| September 21, 2026 | 2.133 |
| September 18, 2026 | 2.094 |
| September 17, 2026 | 2.066 |
| September 16, 2026 | 2.023 |
| September 15, 2026 | 2.055 |
| September 14, 2026 | 2.09 |
| September 11, 2026 | 2.086 |
| September 10, 2026 | 2.035 |
| September 09, 2026 | 2.070 |
| September 08, 2026 | 2.231 |
| September 04, 2026 | 2.290 |
| September 03, 2026 | 2.286 |
| Date | Value |
|---|---|
| September 02, 2026 | 2.239 |
| September 01, 2026 | 2.157 |
| August 31, 2026 | 2.102 |
| August 28, 2026 | 2.106 |
| August 27, 2026 | 2.141 |
| August 26, 2026 | 2.165 |
| August 25, 2026 | 2.133 |
| August 24, 2026 | 2.165 |
| August 21, 2026 | 2.133 |
| August 20, 2026 | 2.106 |
| August 19, 2026 | 2.196 |
| August 18, 2026 | 2.074 |
| August 17, 2026 | 2.051 |
| August 14, 2026 | 2.011 |
| August 13, 2026 | 1.992 |
| August 12, 2026 | 1.988 |
| August 11, 2026 | 1.984 |
| August 10, 2026 | 1.972 |
| August 07, 2026 | 2.062 |
| August 06, 2026 | 1.960 |
| August 05, 2026 | 1.866 |
| August 04, 2026 | 1.846 |
| August 03, 2026 | 1.811 |
| July 31, 2026 | 1.846 |
| July 30, 2026 | 1.862 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.6242 |
| CorMedix, Inc. | 1.245 |
| Eloxx Pharmaceuticals, Inc. | 1.174 |
| Breakthrough Chemistry, Inc. | 2.044 |
| BioStem Technologies, Inc. | 1.613 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0827 |
| Price | 5.145 |
| Earnings Yield | -40.65% |
| Market Cap | 412.65M |
| PEGY Ratio | -0.0827 |